National Lab Briefs

Politicians Rally To Save SERI Can Colorado’s congressional delegation rescue the Solar Energy Research Institute? The Golden, Colo. based lab, whose Department of Energy funding has been sliced nearly in half over the last eight years,’ is facing an additional 32% cut for fiscal 1990, which begins in October. Although Congress has traditionally boosted low presidential requests for solar research, members of the state delegation fear that the federal deficit will make such a rescu

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Can Colorado’s congressional delegation rescue the Solar Energy Research Institute? The Golden, Colo. based lab, whose Department of Energy funding has been sliced nearly in half over the last eight years,’ is facing an additional 32% cut for fiscal 1990, which begins in October. Although Congress has traditionally boosted low presidential requests for solar research, members of the state delegation fear that the federal deficit will make such a rescue much more difficult this year. The legislators warned colleagues on the Senate Appropriations Committee last month about the need to avoid “a devastating cut for SERI in an already bare-bones budget,” and called for an increase in funding at least to the level of the lab’s current allocation of $52 million. “We’re not just crying wolf," says Sen. William Armstrong (R-Colo.), “If we cut it any more, it’s just gone too far.” The lab has bipartisan support in the committee, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies